OOIR: Observatory of International Research

Papers

(The H4-Index of Open Forum Infectious Diseases is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
603. Misdiagnosis of Lyme Disease in Patients Referred to an Academic Lyme Center	206
711. A Unique Breath Secondary Metabolite Volatile Signature for the Diagnosis of Histoplasmosis	165
1386. Seroprevalence of Strongyloidiasis in Liver Transplant Candidates at a Tertiary-Level Hospital in Newark, NJ	154
265. Rocky Mountain Spotted Fever Encephalopathy	127
92. Characteristics and Outcomes of Deep Brain Stimulation Device Related Infections: Experience from Quaternary Centers	120
115. Variable Use of Diagnostic Codes for Acute Respiratory Infections Across Emergency Departments and Urgent Care Clinics in an Integrated Healthcare System: Implications for Accuracy of Antibiotic	101
248. Outcomes of Patients with Prosthetic Septic Arthritis with Debridement and Implant Retention	97
759. Impact of Clostridium difficile (CD) Nucleic Acid Amplification Test (NAAT) Approval on Hospital-Onset C. difficile Infection (HO-CDI): A Diagnostic Stewardship Intervention	91
421. Effect of SARs-Cov-2 mRNA Vaccination in Healthcare Workers with Household COVID Exposure	88
1012. Neutrophil Function Enhanced by Recombinant Interferon-Gamma in Newborns	82
727. Predictors of Depressive Symptoms in Pregnant Partners in Seroconcordant Couples Living with HIV in Zambézia Province, Mozambique	81
294. Surveillance for Potential Post-Acute COVID-19 Syndrome Medical Complications in the Emergency Department (ED) – A Retrospective Longitudinal Study of ED Patients Who Had Evidence of SARS-CoV-2 I	78
1252. In Vitro Activity of Aztreonam-Avibactam and Comparator Agents Against Enterobacterales from Patients with Bloodstream Infections collected during the ATLAS Global Surveillance Program, 2	72
1414. Real-World Study of Healthcare Resource Use and Costs Associated with Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the United States	71
1133. Opportunities for Antibiotic Discontinuation and De-escalation after Discharge from the Emergency Department in Pediatric Patients with UTI	70
706. Effect of the Covid-19 Pandemic on Rates of Recurrent Clostridiodes difficile Infection in the Veterans Affairs System	69
398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States	65
426. COVID-19 Infection Prevention Practices That Exceed CDC Guidance: Balancing Extra Caution Against Impediments to Care	61
1374. Clinical Outcomes of Sepsis According to Race at University of Minnesota Medical Center	57
59. Risk Factors for Recurrent Gram-Negative Bacterial Bloodstream Infections	57
1339. Impact of COVID-19 Pandemic on Activity of Other Respiratory Viral Pathogen and Norovirus	56
969. Gamification for Infectious Diseases Medical Education: Creating a Videogame to Teach COVID 19 Diagnosis and Treatment to Medical Students	55
1232. In Vitro Activity of Cefiderocol and Comparator Agents against Molecularly characterized Carbapenem-resistant Enterobacterales Clinical Isolates Causing Infection in United States	55
1245. In Vitro Activities of Ceftaroline and Comparator Agents Against Bacterial Pathogens Collected from Patients with Skin and Skin Structure Infections: ATLAS Global Surveillance Program 201	55
01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Yo	50

567. Reasons for Deferral of COVID-19 Vaccines Among Arab American Healthcare Professionals Living in the United States	49
645. Rapid Diagnosis of Disseminated Mycobacterium kansasii infection in Renal Transplant Recipients Using Plasma Microbial Cell Free DNA Next Generation Sequencing	49
20. Risk Factors for Breakthrough Cytomegalovirus (CMV) Infection and De Novo Resistance in Hematopoietic Cell Transplantation (HCT) Recipients Receiving Letermovir Prophylaxis	49
433. Role of Community Vaccination Coverage in Controlling Future COVID-19 Outbreaks in Nursing Homes: A Modeling Study	49
516. Evaluation of COVID-19 Monoclonal Antibody Therapies for the Treatment of Non-hospitalized Patients with COVID-19	47
198. Evaluation of Oral Step-down versus Continued Intravenous Antimicrobial Therapy in Immunocompromised Patients Hospitalized with Gram-Negative Bacteremia	47
1384. Practice Variations in Pre-Hematopoietic Stem Cell Transplantation Infectious Disease Evaluation	44
147. Defining the Optimal Serial Testing Interval and Features for Identifying Patients with Early SARS-CoV-2 Infection	42
896. Examining the Impact of the COVID-19 Pandemic on Delivery of HIV Care and Prevention Services Among Patients in a Ryan White Clinic	41
199. Polymorphisms in Key Regulatory Regions of the bla operon Correlate with the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus (MSSA)	41
1299. Epidemiology of Invasive Pneumococcal Disease (IPD) in the United States 2011-2019	41
1350. Characterization of the Type of Specimen Used for Testing of Sexually Transmitted Infections in Outpatient Clinics	41
841. Survey of Current HIV and HCV Policies and Practices in Prisons and Jails Serving High-Risk Geographic Hotspots	41
500. A Real-World Cohort Study of Bamlanivimab Versus Bamlanivimab-Etesevimab for Non-severe COVID-19	41
59. Impact of Pharmacist-Led De-Escalation of MRSA Therapy Using MRSA Nasal PCR	40
27. Co-infections and antimicrobial use in patients hospitalized with COVID-19	40